Evaluation of Efficacy, Effectiveness, and Implementation of Jaspr Health's Digital Platform in Emergency Department for Patients With Suicidal Risk- Part A: Randomized Controlled Trial

What this Trial Is About

Researchers are evaluating a multi-component suicide prevention technology called Jaspr Health during emergency department visits for patients at suicidal risk. The study aims to assess the efficacy, effectiveness, and implementation of Jaspr's tablet-based app, which delivers evidence-based suicide prevention practices and replaces waiting time with productive coping activities. This trial uses a Complementary Randomized Controlled Trial and Real-World Study design to better understand how Jaspr supports suicide prevention in emergency settings. Participants will be randomly assigned to one of two groups. One group will receive enhanced treatment as usual (ETAU), which includes behavioral health evaluation, environmental safety measures, and personalized safety planning. The other group will receive ETAU plus access to the Jaspr app, which guides patients through a suicide risk assessment and provides safety planning, coping skills training, and inspirational videos. After discharge, participants can continue accessing Jaspr's mobile app for ongoing support. Throughout the study, participants will complete a baseline assessment and follow-up phone calls at 6, 12, 24, 36, and 52 weeks to monitor suicide-related outcomes and healthcare use. Researchers will also review death registry data and electronic health records. The primary outcome measured is a composite suicide outcome 12 months after enrollment, with secondary measures including suicide attempts, suicidal behavior, and severity of suicidal thoughts. The study participation lasts one year with ongoing monitoring.

Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A